Hualan Biological Engineering (SZSE:002007) Receivables Turnover : 0.36 (As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Hualan Biological Engineering Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Hualan Biological Engineering's Revenue for the three months ended in Mar. 2024 was ¥787 Mil. Hualan Biological Engineering's average Accounts Receivable for the three months ended in Mar. 2024 was ¥2,200 Mil. Hence, Hualan Biological Engineering's Receivables Turnover for the three months ended in Mar. 2024 was 0.36.

Hualan Biological Engineering Receivables Turnover Historical Data

The historical data trend for Hualan Biological Engineering's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hualan Biological Engineering Receivables Turnover Chart

Hualan Biological Engineering Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Receivables Turnover

Get a 7-Day Free Trial

3.95

3.70

2.48

2.22

2.36

Hualan Biological Engineering Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Receivables Turnover	Get a 7-Day Free Trial															0.41	0.40	1.13	0.58	0.36

Competitive Comparison of Hualan Biological Engineering's Receivables Turnover

For the Biotechnology subindustry, Hualan Biological Engineering's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hualan Biological Engineering's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hualan Biological Engineering's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Hualan Biological Engineering's Receivables Turnover falls into.

Hualan Biological Engineering Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Hualan Biological Engineering's Receivables Turnover for the fiscal year that ended in Dec. 2023 is calculated as

	Receivables Turnover (A: Dec. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Dec. 2023 )	/ (	(Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )
=	5341.873	/ (	(2231.569	+	2295.645)	/	2 )
=	5341.873	/	2263.607
=	2.36

Hualan Biological Engineering's Receivables Turnover for the quarter that ended in Mar. 2024 is calculated as

	Receivables Turnover (Q: Mar. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Mar. 2024 )	/ (	(Accounts Receivable (Q: Dec. 2023 )	+	Accounts Receivable (Q: Mar. 2024 ))	/	count )
=	787.309	/ (	(2295.645	+	2103.542)	/	2 )
=	787.309	/	2199.5935
=	0.36

Hualan Biological Engineering (SZSE:002007) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Hualan Biological Engineering Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Hualan Biological Engineering's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Hualan Biological Engineering (SZSE:002007) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hualan Biological Engineering Inc (SZSE:002007) » Definitions » Receivables Turnover

Traded in Other Exchanges

N/A

Address

No. A1 Hualan Avenue, Henan Province, Xinxiang, CHN, 453003

Website

http://www.hualanbio.com

Hualan Biological Engineering Inc is a China-based biopharmaceutical company. It is engaged in the research, development, production, and commercialization of plasma products, viral vaccines, bacterial vaccines, and recombinant proteins and other biologics. The plasma products offered by the company include Human albumin, Human fibrinogen, Human tetanus immunoglobulin and others. The vaccines products include Recombinant hepatitis B vaccine, Inactivated influenza vaccine and other. It also offers gene products such as Monoclonal Antibody for tumor, autoimmune diseases, infectious diseases, transplant rejection, and Recombinant monoclonal antibodies.

Executives

An Kang	Directors, executives
Pan Ruo Wen	Executives
An Wen Qi	Executives
Wang Qi Ping	Directors, executives
Fan Bei	Directors, executives
Ma Xiao Wei	Executives
Xie Jun Min	Directors, executives
Zhang Bao Xian	Executives
Lv Cheng Yu	Securities Affairs Representative
Zhang Jin Gang	Independent director
Wang Li Ting	Independent director
Ma Li	Supervisors
Sun Zhen Guo	Supervisors
Chen Lei Shan	Supervisors
Yang Bao Ping	Supervisors

Hualan Biological Engineering (SZSE:002007) Headlines

No Headlines